QURE

uniQure N.V. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website uniqure.com
Employees(FY) 501
ISIN NL0010696654

Performance

-15.3%

-11.21%

-13.24%

+13.77%

-15.81%

YTD

-18.16%

Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

Advanced Technical Analysis

Technical Analysis of QURE 2024-11-20

The stock's indicators reflect a bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 36 suggesting continued weakness, and a Technical Score of 23 reinforcing the overall negative outlook. Collectively, these scores signal caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of QURE

Stock Rank

Recent News & Updates

2024-11-07 20:55
Wall Street Analysts Believe uniQure (QURE) Could Rally 169.18%: Here's is How to Trade(Yahoo Finance)
2024-11-04 19:30
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-11-04 18:26
UniQure: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-04 18:05
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress(Globenewswire)
2024-10-28 22:01
UniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release(Yahoo Finance)
2024-10-18 03:03
State Street Corp's Strategic Reduction in uniQure NV Holdings(Yahoo Finance)
2024-10-14 19:05
uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment of SOD1-ALS(Yahoo Finance)
2024-10-14 19:05
uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS(Globenewswire)
2024-09-22 19:05
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease(Globenewswire)
2024-08-14 19:05
uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease(Globenewswire)
2024-08-01 00:51
UniQure restructuring to claim 300 jobs(Yahoo Finance)
2024-07-31 20:25
UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-07-31 19:22
UniQure: Q2 Earnings Snapshot(Yahoo Finance)
2024-07-31 19:05
uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update(Globenewswire)
2024-07-25 21:55
Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High?(Yahoo Finance)
2024-07-22 19:05
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen(Globenewswire)
2024-07-11 19:12
uniQures shares soar on positive data for Huntingtons gene therapy(Yahoo Finance)
2024-07-10 09:55
Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet(Zacks)
2024-07-10 09:01
uniQure (QURE) Soars on New Huntington's Disease Study Data(Zacks)
2024-07-09 17:49
uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?(Yahoo Finance)
2024-07-09 07:05
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease(GlobeNewswire)
2024-07-08 22:46
MULN Stock Alert: Mullen Announces EV Sale to Spencer Manufacturing(Investorplace)
2024-07-08 22:27
Why Is uniQure (QURE) Stock Up 51% Today?(Investorplace)
2024-07-08 21:35
Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)(Yahoo Finance)
2024-07-08 20:05
UniQure stock surges on data for Huntingtons gene therapy(Yahoo Finance)
2024-07-08 19:05
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington's Disease(Globenewswire)
2024-07-01 08:20
uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52%(Simply Wall St.)
2024-07-01 08:00
uniQure's Commercial Gene Therapy Operations to be Acquired by Genezen(MT Newswires)
2024-06-30 19:05
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen(Globenewswire)
2024-06-30 19:05
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA(Prnewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.